Ahmed Anwer Ali Rattani, D.Phil., M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Meiosis | 4 | 2021 | 339 | 0.870 |
Why?
|
| Cell Cycle Proteins | 6 | 2021 | 3462 | 0.700 |
Why?
|
| CDC2 Protein Kinase | 2 | 2017 | 220 | 0.580 |
Why?
|
| Anaphase | 2 | 2014 | 120 | 0.500 |
Why?
|
| Chromosomes | 1 | 2017 | 596 | 0.470 |
Why?
|
| Centromere | 4 | 2021 | 220 | 0.460 |
Why?
|
| Insulinoma | 2 | 2023 | 124 | 0.440 |
Why?
|
| Kinetochores | 4 | 2021 | 194 | 0.410 |
Why?
|
| Chromosomal Proteins, Non-Histone | 3 | 2021 | 736 | 0.320 |
Why?
|
| Hypoglycemia | 2 | 2023 | 861 | 0.270 |
Why?
|
| Oocytes | 4 | 2021 | 1187 | 0.270 |
Why?
|
| Cell Cycle | 1 | 2013 | 2967 | 0.260 |
Why?
|
| Chromatids | 3 | 2014 | 63 | 0.260 |
Why?
|
| Insulin Antagonists | 1 | 2023 | 20 | 0.230 |
Why?
|
| Endopeptidases | 2 | 2012 | 772 | 0.160 |
Why?
|
| Antimalarials | 1 | 2004 | 905 | 0.150 |
Why?
|
| cdc25 Phosphatases | 1 | 2017 | 62 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2017 | 299 | 0.140 |
Why?
|
| Malaria, Falciparum | 1 | 2004 | 1077 | 0.140 |
Why?
|
| Pancreatic Neoplasms | 2 | 2023 | 5256 | 0.130 |
Why?
|
| Genomic Imprinting | 1 | 2017 | 328 | 0.130 |
Why?
|
| Nondisjunction, Genetic | 1 | 2014 | 24 | 0.120 |
Why?
|
| Germinal Center | 1 | 2017 | 377 | 0.120 |
Why?
|
| RNA, Neoplasm | 1 | 2017 | 769 | 0.120 |
Why?
|
| Cyclin B | 1 | 2014 | 108 | 0.120 |
Why?
|
| Cyclin A2 | 1 | 2012 | 21 | 0.110 |
Why?
|
| Protein Phosphatase 2 | 1 | 2013 | 229 | 0.100 |
Why?
|
| Osteosarcoma | 1 | 2017 | 881 | 0.100 |
Why?
|
| Mice, Knockout | 2 | 2017 | 14557 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2013 | 2839 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2011 | 473 | 0.080 |
Why?
|
| Insulin | 1 | 2023 | 6580 | 0.080 |
Why?
|
| Biological Clocks | 1 | 2011 | 321 | 0.080 |
Why?
|
| alpha-Defensins | 1 | 2007 | 28 | 0.080 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2021 | 1888 | 0.070 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2007 | 88 | 0.070 |
Why?
|
| Calcium Oxalate | 1 | 2007 | 74 | 0.070 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2021 | 2752 | 0.070 |
Why?
|
| Mitosis | 1 | 2011 | 1208 | 0.070 |
Why?
|
| Models, Theoretical | 1 | 2017 | 3589 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 2529 | 0.060 |
Why?
|
| Peroxidase | 1 | 2007 | 611 | 0.060 |
Why?
|
| Animals | 7 | 2021 | 168757 | 0.060 |
Why?
|
| Pakistan | 1 | 2004 | 295 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2013 | 13815 | 0.060 |
Why?
|
| Mice | 5 | 2021 | 81183 | 0.060 |
Why?
|
| Kidney Calculi | 1 | 2007 | 465 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 18111 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2014 | 8436 | 0.050 |
Why?
|
| Protein Binding | 1 | 2013 | 9386 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2017 | 3752 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2004 | 1609 | 0.040 |
Why?
|
| Utah | 1 | 2017 | 126 | 0.040 |
Why?
|
| Antibodies | 1 | 2023 | 2460 | 0.030 |
Why?
|
| Plasmodium falciparum | 1 | 2004 | 1732 | 0.030 |
Why?
|
| Models, Biological | 1 | 2011 | 9583 | 0.030 |
Why?
|
| Cyclin B1 | 1 | 2012 | 52 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2013 | 195 | 0.030 |
Why?
|
| Metaphase | 1 | 2012 | 151 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2017 | 1758 | 0.030 |
Why?
|
| Chromosome Segregation | 1 | 2012 | 235 | 0.020 |
Why?
|
| ROC Curve | 1 | 2017 | 3527 | 0.020 |
Why?
|
| Female | 4 | 2017 | 380194 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2012 | 671 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 3616 | 0.020 |
Why?
|
| Male | 3 | 2017 | 350118 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 6895 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 503 | 0.020 |
Why?
|
| Humans | 6 | 2023 | 744343 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2007 | 2255 | 0.020 |
Why?
|
| Boston | 1 | 2017 | 9313 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2017 | 10252 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2007 | 1572 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2017 | 4286 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 7722 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 12354 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 8428 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9438 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16689 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3870 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2012 | 5021 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2012 | 19229 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 29063 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11524 | 0.010 |
Why?
|
| Peptides | 1 | 2007 | 4409 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 63114 | 0.010 |
Why?
|